Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Pharma Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Nippon India | ABSL |
| NAV | ₹591.2429 | ₹47.4890 |
| NAV date | 20 Nov 2026 | 19 Nov 2026 |
| History | 20.6 years | 19.0 years |
| Expense ratio | 1.8% | 2.5% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 78.10 | 78.50 |
Returns
| Nippon India Pharma Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| 1 month | +11.32% | −8.57% |
| 3 months | +3.52% | −10.56% |
| 6 months | +8.09% | −8.70% |
| YTD | +16.05% | +1.69% |
| 1 year | +14.27% | +7.42% |
| 3 years (CAGR) | +16.91% | +16.42% |
| 5 years (CAGR) | +14.37% | +9.07% |
| 10 years (CAGR) | +15.58% | +11.54% |
| Since launch | +17.64% | +8.55% |
Risk
| Nippon India Pharma Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| Volatility | 14.1% | 13.0% |
| Downside volatility | 9.1% | 7.8% |
| Sharpe | 0.74 | 0.76 |
| Sortino | 1.15 | 1.27 |
| Calmar | 1.14 | 1.18 |
| Return / risk | 1.20 | 1.26 |
| Deepest fall | −47.36% | −40.18% |
| Days to recover | 301 | 1215 |
| Below its high | +0.00% | −12.34% |
Against benchmark
| Nippon India Pharma Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| Alpha | −2.75% | +9.00% |
| Beta | 0.89 | 0.08 |
| R² | 89.5% | 1.0% |
| Up capture | 83.5% | 41.3% |
| Down capture | 91.2% | −26.2% |
| Tracking error | 4.8% | 19.7% |
| Information ratio | −0.88 | 0.20 |
| Treynor | 0.11 | 1.15 |
Consistency
| Nippon India Pharma Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| Best 1-year | +175.79% | +56.16% |
| Middle 1-year | +13.84% | +10.88% |
| Worst 1-year | −36.67% | −35.25% |
| 1-year periods with a loss | 23.4% | 17.3% |
| Middle 3-year | +20.93% | +11.20% |
| Positive months | 63.9% | 66.7% |
| Best day | +3.40% | +2.91% |
| Worst day | −3.21% | −4.85% |
| Worst 5% day | −1.38% | −1.21% |
| Positive days | 53.7% | 57.1% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Nippon India Pharma Fund | Aditya Birla Sun Life International Equity Fund | |
|---|---|---|
| 5-year XIRR | +17.18% | +12.45% |
| 5-year value | ₹9,29,284 | ₹8,24,933 |
| 3-year XIRR | +13.26% | +12.83% |
| 1-year XIRR | +21.05% | −6.85% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.